Prostate-specific antigen, clinical use and staging: an overview.
about
Proteolytic activity of prostate-specific antigen (PSA) towards protein substrates and effect of peptides stimulating PSA activityProstate volume and prostate-specific antigen in men with Parkinson's disease are not different compared to age-matched control group: A prospective, case-controlled multicenter study.Prognostic value of serum markers for prostate cancer.KLK-targeted Therapies for Prostate Cancer.Complex formation between human prostate-specific antigen and protease inhibitors in mouse plasma.Mimetics of the disulfide bridge between the N- and C-terminal cysteines of the KLK3-stimulating peptide B-2.Oxibendazole inhibits prostate cancer cell growth.PSA forms complexes with α1-antichymotrypsin in prostate.
P2860
Q34215885-37A28765-0039-4714-A687-8C60EA1D4F1AQ35826615-DB167B62-9FA0-4DB9-A349-0C40A4DCABC9Q36194964-0E2C0476-333E-4482-866C-592F71FEEFC9Q38967486-A72778D0-EB83-4F85-9B9F-0D6AA581E0C9Q39770904-F62E039E-3293-429A-AE45-EE10638B5F10Q43228344-BFBADA93-3983-4D3D-9B4F-AB146B9550D3Q49530055-9425BBF7-039D-472A-BBB6-338BA8D2EB8AQ55056442-6B434DDC-1EC7-4B82-93D1-2CB2E3955920
P2860
Prostate-specific antigen, clinical use and staging: an overview.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Prostate-specific antigen, clinical use and staging: an overview.
@en
type
label
Prostate-specific antigen, clinical use and staging: an overview.
@en
prefLabel
Prostate-specific antigen, clinical use and staging: an overview.
@en
P2860
P1476
Prostate-specific antigen, clinical use and staging: an overview.
@en
P2093
Stenman UH
P2860
P356
10.1111/J.1464-410X.1997.TB00802.X
P478
79 Suppl 1
P577
1997-03-01T00:00:00Z